BMRN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 64.44 USD -1.3% Market Closed

Market Cap: $12.5B

	Biomarin Pharmaceutical Inc NASDAQ:BMRN	US
	Fugro NV F:F3DC	NL
S	Smoore International Holdings Ltd OTC:SMORF	CN
G	General Dynamics Corp XBER:GDX	US
	Intesa Sanpaolo SpA XETRA:IES	IT
	Aedifica NV XBRU:AED	BE

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

78% > 80%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

18%

Operating Margin is Increasing

4% > 20%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Declining Net Margin

4% > 2%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.